Clarissa Desjardins

Board Director

Director

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€112k

▼ Sales (0 ops.)

—

Latest filing published 15 May 2026 for INSMED Inc. Read the official filing

Filing timeline

BuySale

Clarissa Desjardins

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+96.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Clarissa Desjardins: trading record in brief

This profile gathers the share dealings of Clarissa Desjardins in INSMED Inc, where the filings describe the role as board member. The record holds 7 filings, for trades running from 12 May 2021 to 13 May 2026.

Every open-market trade on record is a purchase: 1 purchase worth €112k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants.

The latest filing, published on 15 May 2026, reports a share grant in INSMED Inc. The last insider purchase was made public on 22 May 2025, 514 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.